Adaptimmune Annual report pursuant to Section 13 and 15(d)

Accrued expenses and other current liabilities

12 Months Ended

Dec. 31, 2021

Note 9 — Accrued expenses and other current liabilities

Accrued expenses and other current liabilities consisted of the following (in thousands):


	December 31,		December 31,
	2021		2020
Accrued clinical and development expenditure	$	13,436	$	13,081
Accrued employee expenses		11,758		11,825
Other accrued expenditure		4,388		2,126
Other		327		47
	$	29,909	$	27,079